Abbott defends Norvir price increase
May 25 2004 11:00 PM ET
Abbott Laboratories defended a 400% price increase for its HIV protease inhibitor Norvir, telling a government panel on Tuesday that licenses to allow cheaper copies before its patent expiration were unnecessary. AIDS activists and other critics said the company was selling the drug at an unreasonable price after benefiting from a federal grant early in its development. A nonprofit company run by consumer activists, Essential Inventions, has asked the Department of Health and Human Services to invoke a 1980 law to grant licenses for cheaper, generic copies of Norvir before the drug's patent expires in 2014.
Abbott said licenses for generics were unnecessary given the steps the drugmaker has taken to make sure all patients who need Norvir get it. Anyone without insurance or government assistance can get Norvir free, the company said. "Abbott is absolutely committed to ensuring that not a single patient goes without Norvir because of the repricing," said Jeff Leiden, president and chief operating officer for Abbott's pharmaceutical products group, in remarks prepared for delivery at a hearing at the National Institutes of Health.
Norvir is unique in its class because it helps make other HIV-fighting medicines more effective and as such is one of the most commonly used anti-HIV drugs. Abbott last December raised the price of a single 100-milligram capsule to $8.57 from $1.71. Abbott said the price increase reflected Norvir's value and was necessary to help fund future drug development.
Abbott received a $3.47 million NIH grant in 1988 for early research on protease inhibitors. That was less than 1% of the more than $300 million Abbott spent to develop Norvir, the company said. Activists urged the NIH to use the 1980 Bayh-Dole Act, a law designed to make sure consumers have access to government-supported inventions, to license generic copies of Norvir. "The facts in the Abbott case are so extreme that a 'sky is the limit' or 'anything goes' precedent will have been set" on drug prices if the government does not intervene, said James Love, a consumer activist who founded Essential Inventions. (Reuters)
- Gay News, LGBT Rights, Politics, Entertainment | The Advocate
- WATCH: Rep. Polis's Epic Blowup on House Floor Over Immigration
- Holiday Guide: Shop Here, Not There
- WATCH: Colo. Baker Who Refused Gay Wedding Cake Appears In Court
- Op-ed: Stop Judging Tom Daley and Dustin Lance Black
- Morrissey's Gay Relationship Scrubbed From U.S. Edition of Autobiography
- Women WATCH: Lesbians Explain How Lesbians Have Sex - with Visual Aids! December 05 2013 7:57 PM
- Travel Why Travelers Love Palm Springs Airport December 05 2013 7:33 PM
- Travel Turkish Bazaar Opening on Vegas Strip December 05 2013 7:12 PM
- Women WATCH: Nurse: 3D is the Epic Lesbian Exploitation Hospital Thriller of the Year! December 05 2013 6:54 PM
- No More Bullying WATCH: It Gets Better Speaks to Russian LGBT Youth December 05 2013 6:33 PM
- World News LGBT Rights Are 'Essential Part' of U.S. Foreign Policy, Says Susan Rice December 05 2013 6:15 PM
- Marriage Equality Judge Expected to Rule on Utah Marriage Ban Early Next Year December 05 2013 6:00 PM